Detalles de la búsqueda
1.
Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens.
J Clin Immunol
; 43(6): 1414-1425, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37160610
2.
Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.
Clin Exp Immunol
; 210(2): 91-103, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36208448
3.
Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study.
J Clin Immunol
; 37(6): 603-612, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28755067
4.
Efficacy, Safety, and Pharmacokinetics of a New 10 % Liquid Intravenous Immunoglobulin Containing High Titer Neutralizing Antibody to RSV and Other Respiratory Viruses in Subjects with Primary Immunodeficiency Disease.
J Clin Immunol
; 36(6): 590-9, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324887
5.
Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies.
Front Immunol
; 13: 1110388, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36605207
6.
Evaluation of Intravenous Immunoglobulin in Pediatric Acute-Onset Neuropsychiatric Syndrome.
J Child Adolesc Psychopharmacol
; 31(2): 118-128, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33601937
7.
Treatment of children with primary immunodeficiencies with a subcutaneous immunoglobulin 16.5% (cutaquig® [octanorm]).
Immunotherapy
; 13(10): 813-824, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33955240
8.
Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies.
Front Immunol
; 10: 40, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30778345
9.
Intravenous immunoglobulin 10% in children with primary immunodeficiency diseases.
Immunotherapy
; 10(14): 1193-1202, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30088423
10.
Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study.
Eur J Pharm Sci
; 118: 80-86, 2018 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29522908
Resultados
1 -
10
de 10
1
Próxima >
>>